Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Sales | 5,916 | 3,068 | 1,118 | 0 |
| Cost of Goods | 3,742 | 2,023 | 669 | N/A |
| Gross Profit | 2,173 | 1,044 | 449 | N/A |
| Operating Expenses | 18,934 | 16,110 | 9,027 | 0 |
| Operating Income | -16,019 | -15,042 | -7,909 | N/A |
| Interest Expense | 1,286 | 618 | 31 | 0 |
| Other Income | -60 | 133 | 21 | 0 |
| Pre-tax Income | -17,365 | -15,527 | -7,919 | 0 |
| Income Tax | -552 | N/A | -618 | N/A |
| Net Income Continuous | -16,813 | -15,527 | -7,301 | N/A |
| Net Income | $-16,813 | $-15,527 | $-7,301 | $N/A |
| EPS Basic Total Ops | -1.81 | -2.38 | -1.39 | N/A |
| EPS Basic Continuous Ops | -1.81 | -2.38 | -1.39 | N/A |
| EPS Diluted Total Ops | -1.81 | -2.38 | -1.39 | N/A |
| EPS Diluted Continuous Ops | -1.81 | -2.38 | -1.39 | N/A |
| EBITDA(a) | $-15,587 | $-14,685 | $-7,722 | $N/A |